Healthcare

Market Access
nine for 2023

Nine for 2023, part three: thriving or surviving?

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry

R&D
JP Morgan day 2

JP Morgan 2023 – Day 2

Tuesday brings the on-site part of Fierce’s JPM event as well as day 2 of the Informa Biotech Showcase.